These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 24822060)
21. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853 [TBL] [Abstract][Full Text] [Related]
22. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas. Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021 [TBL] [Abstract][Full Text] [Related]
23. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer. Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637 [TBL] [Abstract][Full Text] [Related]
24. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma. Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070 [TBL] [Abstract][Full Text] [Related]
25. CpG island methylator phenotype is an independent predictor of survival after curative resection for colorectal cancer: A prospective cohort study. Kim CH; Huh JW; Kim HR; Kim YJ J Gastroenterol Hepatol; 2017 Aug; 32(8):1469-1474. PubMed ID: 28087988 [TBL] [Abstract][Full Text] [Related]
26. Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX. Lee DW; Han SW; Cha Y; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Kang GH; Kim TY Clin Epigenetics; 2015; 7(1):63. PubMed ID: 26157509 [TBL] [Abstract][Full Text] [Related]
27. CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. Van Rijnsoever M; Elsaleh H; Joseph D; McCaul K; Iacopetta B Clin Cancer Res; 2003 Aug; 9(8):2898-903. PubMed ID: 12912934 [TBL] [Abstract][Full Text] [Related]
28. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Barault L; Charon-Barra C; Jooste V; de la Vega MF; Martin L; Roignot P; Rat P; Bouvier AM; Laurent-Puig P; Faivre J; Chapusot C; Piard F Cancer Res; 2008 Oct; 68(20):8541-6. PubMed ID: 18922929 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. Nosho K; Irahara N; Shima K; Kure S; Kirkner GJ; Schernhammer ES; Hazra A; Hunter DJ; Quackenbush J; Spiegelman D; Giovannucci EL; Fuchs CS; Ogino S PLoS One; 2008; 3(11):e3698. PubMed ID: 19002263 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of CpG island methylator phenotype among hepatocellular carcinoma patients: A systematic review and meta-analysis. Wang Q; Wang G; Liu C; He X Int J Surg; 2018 Jun; 54(Pt A):92-99. PubMed ID: 29698791 [TBL] [Abstract][Full Text] [Related]
31. Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision. Donada M; Bonin S; Barbazza R; Pettirosso D; Stanta G BMC Gastroenterol; 2013 Feb; 13():36. PubMed ID: 23446022 [TBL] [Abstract][Full Text] [Related]
32. CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer. Chen KH; Lin LI; Tseng LH; Lin YL; Liau JY; Tsai JH; Liang JT; Lin BR; Cheng AL; Yeh KH Oncology; 2019; 96(3):156-163. PubMed ID: 30540994 [TBL] [Abstract][Full Text] [Related]
33. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Ogino S; Kawasaki T; Kirkner GJ; Suemoto Y; Meyerhardt JA; Fuchs CS Gut; 2007 Nov; 56(11):1564-71. PubMed ID: 17339237 [TBL] [Abstract][Full Text] [Related]
34. Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma. Koh YW; Chun SM; Park YS; Song JS; Lee GK; Khang SK; Jang SJ Tumour Biol; 2016 Aug; 37(8):10675-84. PubMed ID: 26867769 [TBL] [Abstract][Full Text] [Related]
35. A CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps. Hokazono K; Ueki T; Nagayoshi K; Nishioka Y; Hatae T; Koga Y; Hirahashi M; Oda Y; Tanaka M Oncol Lett; 2014 Nov; 8(5):1937-1944. PubMed ID: 25289081 [TBL] [Abstract][Full Text] [Related]
36. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients. Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093 [TBL] [Abstract][Full Text] [Related]
37. Wang C; Liu Y; Guo W; Zhu X; Ahuja N; Fu T Cancer Manag Res; 2019; 11():7337-7343. PubMed ID: 31496795 [TBL] [Abstract][Full Text] [Related]
38. No association of CpG island methylator phenotype and colorectal cancer survival: population-based study. Jia M; Jansen L; Walter V; Tagscherer K; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M Br J Cancer; 2016 Nov; 115(11):1359-1366. PubMed ID: 27811854 [TBL] [Abstract][Full Text] [Related]
39. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma]. Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763 [TBL] [Abstract][Full Text] [Related]
40. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]